Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 304

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Pancreatic Adenocarcinoma, Version 2.2012: Featured Updates to the NCCN Guidelines

Open access
Tempero, Margaret A., Arnoletti, J. Pablo, Behrman, Stephen W., Ben-Josef, Edgar, Benson, Al B., Casper, Ephraim S., Cohen, Steven J., Czito, Brian, Ellenhorn, Joshua D. I., Hawkins, William G., Herman, Joseph, Hoffman, John P., Ko, Andrew, Komanduri, Srinadh, Koong, Albert, Ma, Wen Wee, Malafa, Mokenge P., Merchant, Nipun B., Mulvihill, Sean J., Muscarella, Peter, Nakakura, Eric K., Obando, Jorge, Pitman, Martha B., Sasson, Aaron R., Tally, Anitra, Thayer, Sarah P., Whiting, Samuel, Wolff, Robert A., Wolpin, Brian M., Freedman-Cass, Deborah A., Shead, Dorothy A.·2012·Journal of the National Comprehensive Cancer Network
DOI 10.6004/jnccn.2012.0073
Open this paper in CoChat — free account

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pancreatic Adenocarcinoma discuss the workup and management of tumors of the exocrine pancreas. These NCCN Guidelines Insights provide a summary and explanation of major changes to the 2012 NCCN Guidelines for Pancreatic Adenocarcinoma. The panel made 3 significant updates to the guidelines: 1) more detail was added regarding multiphase CT techniques for diagnosis and staging of pancreatic cancer, and pancreas protocol MRI was added as an emerging alternative to CT; 2) the use of a fluoropyrimidine plus oxaliplatin (e.g., 5-FU/leucovorin/oxaliplatin or capecitabine/oxaliplatin) was added as an acceptable chemotherapy combination for patients with advanced or metastatic disease and good performance status as a category 2B recommendation; and 3) the panel developed new recommendations concerning surgical technique and pathologic analysis and reporting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2012.0073

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 304

Metadata

Authors
Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben-Josef, E., Benson, A. B., Casper, E. S., Cohen, S. J., Czito, B., Ellenhorn, J. D. I., Hawkins, W. G., Herman, J., Hoffman, J. P., Ko, A., Komanduri, S., Koong, A., Ma, W. W., Malafa, M. P., Merchant, N. B., Mulvihill, S. J., Muscarella, P., Nakakura, E. K., Obando, J., Pitman, M. B., Sasson, A. R., Tally, A., Thayer, S. P., Whiting, S., Wolff, R. A., Wolpin, B. M., Freedman-Cass, D. A., & Shead, D. A.
Venue
Journal of the National Comprehensive Cancer Network
Publisher
Harborside Press, LLC
Published
2012-06
Volume
10
Issue
6
Pages
703-713
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
DOI
10.6004/jnccn.2012.0073
OpenAlex
W2160273106
Cited by
304
References
28
FWCI
19.46
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pancreatic Adenocarcinoma, Version 2.2012: Featured Updates to the NCCN Guidelines. https://app.cochat.ai/papers/10.6004/jnccn.2012.0073
The paper
Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben-Josef, E., Benson, A. B., Casper, E. S., Cohen, S. J., Czito, B., Ellenhorn, J. D. I., Hawkins, W. G., Herman, J., Hoffman, J. P., Ko, A., Komanduri, S., Koong, A., Ma, W. W., Malafa, M. P., Merchant, N. B., Mulvihill, S. J., . . . Shead, D. A. (2012). Pancreatic Adenocarcinoma, Version 2.2012: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2012.0073

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.